MCL1 and neoplasm: It was also reported that sorafenib induces tumor cell death via various MAPK-independent mechanisms, including down-regulation of anti-apoptotic Bcl-2 proteins such as myeloid cell leukemia-1 (Mcl-1) and up-regulation of p53 [10].